Table 14 lists ongoing clinical trials of albumin NPs for pancreatic cancer in this field, which currently focus on the development of new drugs such as albumin-bound docetaxel and combination treatment regimens based on nab-paclitaxel. This evidence concerns the gene ALB and familial pancreatic carcinoma.